Osteoporosis Choice Decision Aid for Use of Bisphosphonates in Postmenopausal Women
NCT00578981 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2016-02-02
Summary
To develop a decision aid to support the decision to use (or not use) bisphosphonates in postmenopausal women at risk for osteoporotic fractures, and to assess the impact of the decision aid on start and six month adherence to bisphosphonates.
Conditions
- Osteoporosis
- Bone Loss, Age Related
- Postmenopausal Bone Loss
- Postmenopausal Osteoporosis
Interventions
- BEHAVIORAL
-
Osteoporosis Choice Decision Aid
The provider will introduce the patient to the choice of bisphosphonates using the decision aid.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Victor M. Montori, M.D. · Mayo Clinic
Study Design
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Model
- FACTORIAL
Eligibility
- Min Age
- 50 Years
- Max Age
- 90 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-08-31
- Primary Completion
- 2008-07-31
- Completion
- 2008-07-31
Countries
- United States
Study Locations
More Related Trials
-
Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076)
NCT01803607 ·Status: TERMINATED ·Phase: PHASE3
-
A Study to Evaluate Denosumab in the Treatment of Postmenopausal Osteoporosis
NCT00089791 ·Status: COMPLETED ·Phase: PHASE3
-
Bisphosphonate Action on the Appendicular Skeleton: Evidence for Differential Effects
NCT00666627 ·Status: COMPLETED ·Phase: PHASE2
-
Adherence to Osteoporosis Treatment and Physicians' Perception Regarding Osteoporosis Medication
NCT02472782 ·Status: COMPLETED
-
Evaluation of Adherence With Bisphosphonates and Calcium and Vitamin D Supplements in Women With Postmenopausal Osteoporosis
NCT07105163 ·Status: RECRUITING
-
Study to Evaluate Efficacy of Odanacatib (MK-0822) on Bone Mineral Density (BMD) and Bone Micro-architecture and Overall Safety in Postmenopausal Women (MK-0822-031)
NCT00729183 ·Status: COMPLETED ·Phase: PHASE3
-
Risedronate In The Prevention Of Osteoporosis In Osteopenic Postmenopausal Women
NCT00353080 ·Status: COMPLETED ·Phase: PHASE3
-
Bisphosphonates for Prevention of Post-Denosumab Bone Loss
NCT03396315 ·Status: COMPLETED ·Phase: PHASE2
-
Risedronate in the Prevention of Osteoporosis in Postmenopausal Women
NCT00402441 ·Status: COMPLETED ·Phase: PHASE4
-
Melatonin-Micronutrients for Osteopenia Treatment Study
NCT01870115 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 2 Dose-finding Study to Evaluate the Effects of BA058 in the Treatment of Postmenopausal Women With Osteoporosis
NCT00542425 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Clinical Safety, Tolerability, and Efficacy of Zoledronic Acid Compared to an Oral Bisphosphonate
NCT00100555 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Bisphosphonate on Bone Loss in Postmenopausal Women With Breast Cancer Initiating Aromatase Inhibitor Therapy
NCT00485953 ·Status: COMPLETED ·Phase: PHASE4
-
Risedronate 75mg Dosed on 2 Consecutive Days Monthly in the Treatment of Osteoporosis in Postmenopausal Women
NCT00358176 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of MK-0822 in Postmenopausal Women With Osteoporosis to Assess Fracture Risk (MK-0822-018)
NCT00529373 ·Status: TERMINATED ·Phase: PHASE3
-
MK-5442 in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated With an Oral Bisphosphonate (MK-5442-012)
NCT00996801 ·Status: COMPLETED ·Phase: PHASE2
-
The Prevention of Osteoporosis in Premenopausal and Newly Postmenopausal (Up to 8 Years) Women With Breast Cancer Following Chemotherapy (REBBeCA Study)
NCT00118508 ·Status: COMPLETED ·Phase: NA
-
Study to Assess Efficacy of Risedronate in Preventing Bone Loss in Postmenopausal Women Treated for Breast Cancer
NCT00859703 ·Status: COMPLETED ·Phase: PHASE3
-
A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis
NCT02157948 ·Status: COMPLETED ·Phase: PHASE3
-
Antiepileptic Drugs and Osteoporotic Prevention Trial
NCT00869622 ·Status: COMPLETED ·Phase: PHASE4
-
Denosumab Adherence Preference Satisfaction Study
NCT00518531 ·Status: COMPLETED ·Phase: PHASE3
-
Dental Care and Initiation of Anti-osteoporotic Therapy
NCT05719818 ·Status: COMPLETED
-
Bone Microarchitecture in Osteopenic Postmenopausal Women
NCT00577395 ·Status: TERMINATED ·Phase: PHASE4
-
Resolution of Effect of Bisphosphonates on Bone in Postmenopausal Osteoporosis
NCT01406613 ·Status: COMPLETED
-
A Randomized, Double-Blind Study to Compare the Efficacy of Treatment With Denosumab Versus Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density.
NCT00330460 ·Status: COMPLETED ·Phase: PHASE3